Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
This is a two-part study designed to evaluate the effect of Estetrol (E4) 15 or 20 mg, or
placebo on the severity and frequency of vasomotor symptoms (VMS) (Efficacy Study Part) and
the safety of E4 20 mg (Endometrial and General Safety Study Part)